Da32 Life Science Tech Acquisition Corp Cl A (DALS)
Da32 Life Science Tech Acquisition Corp Cl A (DALS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | 1,953 | 165 |
| TOTAL | $N/A | $2,671 | $165 |
| Non-Current Assets | |||
| Investments And Advances | 0 | 200,009 | 0 |
| Other Non-Current Assets | 0 | 0 | 306 |
| TOTAL | $N/A | $200,009 | $306 |
| Total Assets | $N/A | $202,680 | $471 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 0 | 50 |
| Accrued Expenses | N/A | 127 | 198 |
| TOTAL | $N/A | $217 | $489 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 205,600 | 0 |
| TOTAL | $N/A | $205,600 | $N/A |
| Total Liabilities | $N/A | $205,817 | $489 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 25,650 | 5,000 | 5,750 |
| Common Shares | N/A | 1 | 1 |
| Retained earnings | N/A | -3,137 | -43 |
| TOTAL | $N/A | $-3,136 | $-18 |
| Total Liabilities And Equity | $0 | $202,680 | $471 |